Prostate Brachytherapy (Radioactive Seed Implantation) is a procedure that implants radioactive "seeds" into the prostate gland, in order to kill prostate cancer cells.
Seed implantation is often used for men with smaller prostate cancer that is found early and is slow-growing. This form of treatment is well-tolerated, and has fewer side effects and complications than standard radiation therapy. Patients are able to return to work and normal activities within just a few days of the procedure.
The medical team at Cone Health Cancer Center uses cutting-edge software and intraoperative planning to examine three dimensional images of the prostate, and optimize seed distribution using ultrasound guidance. This advanced technology also assists the radiation oncologists in ensuring optimal seed quality, and in monitoring the patient long-term.
Cone Health Cancer Center’s radiation oncologists and medical staff collaborates with urologists and other related healthcare providers throughout the community to develop treatment plans individualized to each patient’s needs. As a part of this multidisciplinary clinical approach and commitment to exceptional care, Cone Health Cancer Center has administered 2,100 prostate implant procedures since 1993, and continues to serve as a leader in this type of cancer treatment.
Dr. Matthew Manning is a radiation oncologist and leading expert on treatment advancements at the Cone Health Cancer Center. Manning is a 1996 graduate of Medical College of Virginia, and completed his residency in radiation oncology at Medical College of Virginia Hospitals.